Pharmaceutical Consultant Biotech's Rise Amid Industry Redundancies

Pharmaceutical Consultant Biotech's Rise Amid Industry Redundancies
In today’s evolving pharmaceutical landscape, Pharmaceutical Consultant Matt Britland discusses the rise of biotech and the increasing industry redundancies. Ten years ago, the pharma industry seemed secure, but now we face significant changes. Discover how biotech presents a new opportunity and hear Matt’s insights on the market’s shift. He identifies key gaps and how Medwise addresses them, offering a fresh perspective on navigating these industry challenges.
Matt shares his journey from big pharma to founding Medwise, detailing the market gaps he saw and the solutions he provided. He explains why medical affairs roles are shifting and how outsourcing is becoming more prevalent. Learn about the expanding role of biotech and why it’s a promising avenue for professionals in the field. This video is a valuable resource for anyone interested in understanding these industry dynamics.
As Matt transitions to biotech and discusses the rising trend of biotech companies submitting INDs, he offers insights into the industry’s future. The conversation highlights the need for specialized external support and how Medwise is pioneering this space in Australia. If you’re interested in the differences between big pharma and biotech or have any questions, drop a comment below. Don’t miss our next video on mastering networking in pharma-click here to elevate your career!
Hashtags:
#PharmaceuticalConsultant, #BiotechRise, #IndustryRedundancies, #MedicalAffairs, #ConsultingIndustry,